The North America cell line development serum market is expected to reach US$ 502.91 million in 2027 from US$ 307.29 million in 2019
The market is expected to grow with a CAGR of 6. 4% from 2020-2027. Increasing adoption of regenerative medicines, rising prevalence of cancer across the world, and increasing investments in R&D; by pharmaceutical and biotechnology companies are the key factors driving the growth of the North America cell line development serum market.New York, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "North America Cell Line Development Serum Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Type ; By Application ; and Country" - ht...